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ABSTRACT:  Local drug delivery directly to the source of a given pathology using retrodialysis is a promising approach to 
treating otherwise untreatable diseases. As the primary material component in retrodialysis, the semi-permeable membrane 
represents a critical point for innovation.  This work presents a new ionic hydrogel based on polyethylene glycol and acrylate 
with dopamine counter ions. The ionic hydrogel membrane is shown to be a promising material for controlled diffusive de-
livery of dopamine. The ionic nature of the membrane accelerates uptake of cationic species compared to a non-ionic mem-
brane of otherwise similar composition. It is demonstrated that the increased uptake of cations can be exploited to confer an 
accelerated transport of cationic species between reservoirs as is desired in retrodialysis applications. This effect is shown to 
enable nearly 10-fold increases in drug delivery rates from low concentration solutions. The processability of the membrane 
is found to allow for integration with microfabricated devices which will in turn accelerate adaptation into both existing and 
emerging device modalities. It is anticipated that a similar materials design approach may be broadly applied to a variety of 
cationic and anionic compounds for drug delivery applications ranging from neurological disorders to cancer. 
Local drug delivery directly to the source of a given pa-
thology using implantable materials and devices is a prom-
ising approach to treating otherwise untreatable diseases. 
This approach is particularly attractive for pathologies 
where systemic drug treatments have been ineffective due 
to an inability to reach the target and/or serious side effects 
from off target drug interactions. Concentration-driven dif-
fusion via retrodialysis (also known as reverse microdialy-
sis) is among the most widely reported local drug delivery 
techniques to date with numerous applications in both re-
search and the clinic1,2. Retrodialysis involves the delivery 
of compounds across a semi-permeable membrane typi-
cally using a microdialysis probe loaded with a perfusate so-
lution of drugs. The technique is simple to apply and offers 
the benefit of continuous drug delivery with minimal local 
pressure increase.  
As the primary material component in retrodialysis, the 
semi-permeable membrane represents a critical point for 
innovation. New membrane materials could expand appli-
cations to allow for efficient delivery of low-concentration 
drug solutions and to accelerate delivery of drugs with poor 
stability. Likewise, new membrane materials that are com-
patible with microfabrication techniques could allow for ad-
aptation of recently reported material/device architectures 
that mitigate the foreign body response. This is particularly 
important as the foreign body response is well known to 
limit the long-term efficacy of medical implants for drug de-
livery and sensing3–6. 
Previous work on microdialysis membranes has sug-
gested that incorporation of fixed ionic groups within the 
membrane can affect the diffusion rate of charged com-
pounds7. We aimed to explore if this effect could also be lev-
eraged for retrodialysis membranes. To that end, we report 
here on a hydrogel based on polyethylene glycol diacrylate 
(PEGDA) and a new ionic monomer, dopamine acrylate 
(iDAA). The iDAA monomer was formulated with dopamine 
(+) as the counter-ion to each acrylate (-) fixed ionic group. 
This also ensured optimal permeability for controlled 
amounts of dopamine within the membrane. 
Dopamine is a neurotransmitter known play an im-
portant role in controlling movement and emotions8,9. The 
death of dopamine-producing cells has long been impli-
cated in Parkinson’s disease and thus local delivery of dopa-
mine and dopamine-like compounds has been the subject of 
much research10–13. PEGDA based materials have been used 
extensively for biological applications14–16 and can be 
photo-patterned in a manner compatible with standard mi-
crofabrication procedures17,18. Hydrated PEGDA based 
membranes are also known to have tunable swelling ratios 
and to be semi-permeable allowing a variety of compounds 
to diffuse through14,19. The combination of biocompatibility, 
processability and permeability makes PEGDA a suitable 
candidate for retrodialysis applications.  
  
Scheme 1 A) Formation of iDAA by exchange of Cl(-) with 
Acrylate(-). B) Combination of PEGDA, iDAA, H2O with a  pho-
toiniator and UV light to form PEGDA-iDAA. 
As shown in scheme 1, the iDAA monomer was prepared 
exchanging the Cl- in dopamine hydrochloride with acrylate 
(-) using an anion exchange resin (Alfa Aesar, Amberlyst A-
26), see Methods for detailed synthetic procedures and 
NMR. iDAA was then mixed with deionized water (up to 1 
M), equal volume of PEGDA (Mn 575, Sigma Aldrich) and 2 
wt% 2-hydroxy-2-methylpropiophenone, a biocompatible 
photoinitiator (Darocur 1173, Sigma Aldric). The mixed so-
lution was deposited as desired and exposed to ultraviolet 
(UV) light (100 µJ/cm2, AnalytikJena UVP Crosslinker) for 
30 minutes to form a fully crosslinked PEGDA-iDAA mem-
brane (see scheme 1B). The composition of the PEGDA-
iDAA membranes were confirmed with FTIR (Figure S1). 
Membranes were also prepared with methyl acrylate (MA) 
in place of iDAA to provide comparison to a noncharged 
membrane. Following UV exposure, membranes were 
soaked in phosphate buffered saline (PBS 0.01M) for at least 
four hours, replacing with fresh PBS solution on an hourly 
basis. The membranes were observed to be stable in PBS 
with no visible degradation up to six months. Likewise, 
membranes were found to exhibit only modest swelling in 
PBS solution with an increase in weight content of no more 
than 11%. The observed stability and minimal swelling sug-
gest a highly cross-linked membrane. The limited swelling 
is particularly important for integration with microfabri-
cated devices as excessive swelling can otherwise stress 
non-swelling materials leading to cracking and issues with 
adhesion.  
As an initial test of compatibility with microfabricated 
devices, PEGDA-iDAA membranes were directly patterned 
onto the end of a 220 µm wide neural probe with an inte-
grated microfluidic channel20 (Figure 1). The patterning of 
the membrane, 200 µm across, was made possible by se-
lected UV exposure of the deposited membrane solution us-
ing standard photolithography techniques (SUSS MicroTec 
MJB4).  Adhesion to the parylene surface of the neural probe 
was aided by pre-treatment with methacryloxypropyl tri-
methoxysilane (Silane A 174, Sigma Aldrich) following pre-
viously reported procedures21. As with the free-standing 
membranes, the PEGDA-iDAA membranes on the microflu-
idic probes exhibited excellent stability with no signs 
degradation in PBS suggesting that the material is well 
suited for retrodialysis applications. 
 
Figure 1: Image of PEGDA-iDAA membrane patterned at 
the end of neural probe with integrated microfluidic chan-
nel. Scale bare 200 µm. 
Following the processability testing, the diffusion/up-
take of molecules in the PEGDA-iDAA membrane was ex-
plored by soaking the membranes in aqueous solutions with 
charged dye molecules. In particular, to understand the ef-
fect of fixed anionic groups in the membrane, three mem-
brane compositions with varying fixed anion concentration 
were compared: PEGDA-MA with 500 mM concentration of 
MA, PEGDA-iDAA-MA with 50 mM concentration iDAA and 
450 mM MA, and PEGDA-iDAA with 500 mM concentration 
iDAA. Each membrane was soaked in 1 mM and 10 mM phe-
nol red solutions (pH 10). After one hour, the membranes 
were removed from the solution gently patted dry and pho-
tographed. They were then placed in a concentrated NaCl 
solution (2M) for one hour during which time absorbed dye 
was released into the NaCl solution. A fixed volume of the 
NaCl solution was then taken for UV-VIS measurements to 
gauge the relative concentration of phenol red.  The same 
procedure was followed using fresh membranes with meth-
ylene blue in place of phenol red. The photographed mem-
branes and UV-VIS results are shown in Figure 1A for phe-
nol red (450 nm) and Figure 1B for methylene blue (670 
nm). The absorption data was normalized by volume of the 
membrane to account for variations in dimensions.  
Prior to soaking membranes in dye solutions, they were 
observed to be transparent with only negligible absorption 
across the visible spectrum. After soaking in phenol red, the 
membranes took a yellow hue that increased with increas-
ing concentration suggesting some up take of the anionic 
dye. The absorbed concentration of phenol red was found 
to be greatest in the uncharged PEGDA-MA membrane with 
decreasing uptake as the concentration of iDAA increased. 
This can be understood by considering that the fixed acry-
late(-) groups in the PEGDA-iDAA membrane act as electro-
static barrier to the diffusion/uptake of anionic compounds 
as is typical for polyanions22. In contrast, the opposite trend 
was observed when membranes were soaked in the cationic 
methylene blue solution with increasing uptake of meth-
ylene blue as the iDAA content increased. In fact, the nor-
malized absorption from methylene blue was more than 
ten-fold higher for the PEGDA-iDAA membrane compared 
to the PEGDA-MA membrane. We posit this phenomenon 
can be explained by considering that the fixed acrylate(-) 
groups are each compensated by a counter ion in the form 
of a freely moving cation. Initially the counter ions are 
A
B
 primarily Na+ and upon introduction of methylene blue(+) 
some portion of counter ions are exchanged. The higher 
 
Figure 2: A) Normalized absorption at 450 nm for PEGDA-
MA, PEGDA-MA-iDAA and PEGDA-iDAA membranes before 
and after soaking in 1mM and 10 mM phenol red solutions 
with images of corresponding membranes above each bar 
(membrane width approximately 1 cm each). B) Normal-
ized absorption at 670 nm for PEGDA-MA, PEGDA-MA-iDAA 
and PEGDA-iDAA membranes before and after soaking in 
1mM and 10 mM methylene blue solutions with images of 
corresponding membranes above each bar (membrane 
width approximately 1 cm each). 
concentration of fixed ions and counter-ions in the mem-
brane compared to concentration of the dye solution drives 
a higher uptake of the cationic methylene blue within the 
membrane than would be expected in the absence of fixed 
charge. Together these results indicate the charged PEGDA-
iDAA membrane is well suited to preferentially transport 
cationic species.  
 
Figure 3: Concentration of dopamine measured in the Tar-
get well as function of time using PEGDA-iDAA and PEGDA-
MA membranes with an initial dopamine concentration of 
12 mM in the Source well. The inset illustrates the relative 
ionic concentration in the Source, membrane and Target. B) 
Schematic showing ion exchange at Source/PEGDA-iDAA 
interface (top) as well as PEGDA-iDAA/Target interface 
(bottom)  at time zero and after some minutes. Brown cati-
ons represent dopamine with sodium represented by red 
cations, fixed acrylate anion in blue and chorine anions in 
green. 
Having observed the ability to preferentially uptake cat-
ionic species at an accelerated rate, the suitability of 
PEGDA-iDAA membranes for retrodialysis of dopamine was 
subsequently tested in a model system. Membranes were 
sandwiched between two wells with the membrane serving 
as a bridge material connecting the contents of each well 
(see Supporting Information). One well was designated as 
the Source side and was filled with an aqueous solution of 
dopamine hydrochloride. The other well served as the Tar-
get and was filled with PBS to mimic the biological environ-
ment. After a set time period, the solution in the Target was 
collected and analyzed with differential pulse voltammetry 
23,24 to measure the amount of dopamine delivered from the 
Source well to the Target well (see Supporting Information). 
Figure 3 shows the measured concentration of dopamine in 
the Target as a function of time for a dopamine Source con-
centration of 12 mM using either the PEGDA-iDAA or 
PEGDA-MA membranes. The inset illustrates the relative 
 initial ion concentrations in the Source, membrane and Tar-
get. It should be noted that membranes were repeatedly 
rinsed and soaked in saline solution to remove any residual 
dopamine prior to starting the dopamine diffusion experi-
ments. For all time points, it was observed that there was 
nearly 10-fold more dopamine transferred from Source to 
Target with the PEGDA-iDAA membrane compared to the 
PEGDA-MA. This is especially noteworthy given that the 
Target contained smaller, more mobile cations (Na) at 
greater than ten times the concentration of dopamine in the 
Source as such conditions are typical for drug delivery ap-
plications20,25,26. We posit that these results can be under-
stood by considering that the relatively high concentration 
of fixed anions in the PEGDA-iDAA membrane leads to an 
enhanced uptake of dopamine from the Source similar to 
what was observed in the charged dye experiments. As the 
PEGDA-iDAA membrane fills with a higher concentration of 
dopamine compared to the uncharged PEGDA-MA mem-
brane, this in turn creates a higher concentration gradient 
for dopamine relative to the Target and thus a higher diffu-
sive flux.  A similar phenomenon has previously been re-
ported for cation transport in porous ion exchange mem-
branes27.  
This ion exchange phenomena is illustrated in Fig. 3B 
wherein a simplified schematic of the ion exchanges are 
shown at the Source/PEGDA-iDAA interface (top) as well as 
PEGDA-iDAA/Target interface (bottom) at time zero and af-
ter some minutes. Brown cations represent dopamine with 
sodium represented by red cations, fixed acrylate anion in 
blue and chorine anions in green (the low concentration of 
phosphate and potassium ions in the Target are excluded 
for clarity). As illustrated, ion exchange facilitates uptake of 
dopamine into the PEGDA-iDAA membrane at the Source 
side and which then leads to dopamine exchange with (pri-
marily) sodium ions at the Target side. Note that this means 
there is also a flux of sodium from Target to Source by the 
same mechanism. 
The drug delivery capacity of the PEGDA membranes 
was explored further using the same Source-membrane-
Target setup to measure the effect of Source concentration. 
Figure 4 shows the concentration of dopamine measured in 
the Target after 30 minutes for Source dopamine concentra-
tions from 1mM to 1.7 M. The figure inset indicates the rel-
ative ion concentrations on a log scale for each region. In the 
case that the Source concentration was less than the fixed 
ion concentration in the PEGDA-iDAA membrane (approx. 
500 mM), a pronounced increase in delivered dopamine 
was observed relative to the PEGDA-MA membrane. How-
ever, the difference in transported dopamine was negligible 
between the two membranes for Source concentrations 
above the PEGDA-iDAA fixed ion concentration. This finding 
supports the notion that the fixed ions in the PEGDA-iDAA 
membrane drive the accelerated diffusion observed at 
lower Source concentrations. When the Source concentra-
tion significantly exceeds the fixed ion concentration in the 
membrane, it follows that after some time the concentration 
of dopamine in the PEGDA-iDAA membrane would be simi-
lar to that observed in the system with the uncharged 
PEGDA-MA membrane. Consequently, in these conditions 
the diffusive flux from Source to Target for both membrane 
systems is primarily a function of the Source concentration 
and is therefore similar in magnitude.  
 
Figure 4: Concentration of dopamine measured in the Tar-
get well as function of dopamine concentration in the 
Source well using PEGDA-iDAA and PEGDA-MA mem-
branes. The inset illustrates the relative ionic concentration 
in the Source, membrane and Target on a log scale.  
Altogether the results presented here suggest that the 
PEGDA-iDAA membrane is a promising material for con-
trolled diffusive delivery of dopamine. The ionic nature of 
the membrane accelerates uptake of cationic species com-
pared to a non-ionic membrane of otherwise similar com-
position. The increased uptake of cations can be exploited 
to confer an accelerated transport of cationic species be-
tween reservoirs as is desired in retrodialysis applications. 
This effect can enable nearly 10-fold increases in drug de-
livery rates from low concentration solutions (< 100 mM). 
Equally important, the processability of the PEGDA-iDAA 
membrane readily enables integration with microfabri-
cated devices which can in turn accelerate adaptation into 
both existing and emerging device modalities. While the 
work here was focused on delivery of dopamine, we antici-
pate that a similar materials design approach may be 
broadly applied to a variety of cationic and anionic com-
pounds for drug delivery applications ranging from neuro-
logical disorders to cancer.  
METHODS 
Synthesis of ionic dopamine acrylate monomer (iDAA): 
The synthesis of iDAA was carried out using an anionic 
exchange resin (AER), Amberlyst A-26 (OH) from Alfa 
Aesar (exchange capacity 0.8 mol/l). An excess (>10% 
p/V) of commercial acrylic acid (Sigma Aldrich) in water 
and 0.05M of dopamine chloride (Alfa Aesar) in metha-
nol. The AER column was loaded with an excess of acrylic 
acid solution (>10% p/V). Then, a 0.05M dopamine chlo-
ride solution in methanol was passed slowly through the 
column. The final product, dopamine acrylate (iDAA), 
was collected in the form of a methanol solution. Metha-
nol was removed under reduced pressure, and the iDAA 
was characterized by 1H NMR (400 MHz, Deuterium Ox-
ide) δ 6.86 – 6.69 (m, 3H, aromatic), 6.13 – 5.60 (m, 3H, 
 CH2=CH), 3.17 (t, 2H, CH2-CH2-NH3), 2.82 (t, 2H, CH2-CH2-
NH3). 
Differential pulse voltammetry (DPV): DPV measure-
ments were performed using a three electrode configu-
ration with a glassy carbon working electrode, Pt-wire  
counter electrode and Ag/AgCl reference electrode using 
an Metrohm Autolab Potentiostat (model PGSTAT128N).  
Glass carbon electrodes were cleaned thoroughly prior 
to each measurement. Unknown concentrations of dopa-
mine were determined using a calibration curve of meas-
ured current at the 0.14V peak for known concentrations 
of dopamine.  
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